163 related articles for article (PubMed ID: 23800034)
1. Molecular characterization of canine BCR-ABL-positive chronic myelomonocytic leukemia before and after chemotherapy.
Culver S; Ito D; Borst L; Bell JS; Modiano JF; Breen M
Vet Clin Pathol; 2013 Sep; 42(3):314-22. PubMed ID: 23800034
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloblastic leukemia with associated BCR-ABL translocation in a dog.
Figueiredo JF; Culver S; Behling-Kelly E; Breen M; Friedrichs KR
Vet Clin Pathol; 2012 Sep; 41(3):362-368. PubMed ID: 22747755
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
[TBL] [Abstract][Full Text] [Related]
4. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias.
Cox MC; Maffei L; Buffolino S; Del Poeta G; Venditti A; Cantonetti M; Aronica G; Aquilina P; Masi M; Amadori S
Am J Clin Pathol; 1998 Jan; 109(1):24-31. PubMed ID: 9426514
[TBL] [Abstract][Full Text] [Related]
5. Aberrations of chromosomes 9 and 22 in acute lymphoblastic leukemia cases detected by ES-fluorescence in situ hybridization.
Cetin Z; Yakut S; Karadogan I; Kupesiz A; Timuragaoglu A; Salim O; Tezcan G; Alanoglu G; Ozbalci D; Hazar V; Yesilipek MA; Undar L; Luleci G; Berker S
Genet Test Mol Biomarkers; 2012 May; 16(5):318-23. PubMed ID: 22360868
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic, fluorescence in situ hybridization, and genomic array characterization of chronic myeloid leukemia with cryptic BCR-ABL1 fusions.
Shao L; Miller S; Keller-Ramey J; Zhang Y; Roulston D
Cancer Genet; 2015; 208(7-8):396-403. PubMed ID: 26186983
[TBL] [Abstract][Full Text] [Related]
7. Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques.
Recchia AG; Caruso N; Bossio S; Pellicanò M; De Stefano L; Franzese S; Palummo A; Abbadessa V; Lucia E; Gentile M; Vigna E; Caracciolo C; Agostino A; Galimberti S; Levato L; Stagno F; Molica S; Martino B; Vigneri P; Di Raimondo F; Morabito F
PLoS One; 2015; 10(6):e0130360. PubMed ID: 26111048
[TBL] [Abstract][Full Text] [Related]
8. The ABL/BCR fusion gene on chromosome 9 in Ph-negative chronic myelogenous leukemia: a case for vigilance in fluorescence in situ hybridization interpretation.
Hsu WT; Preisler H; Szego K; Sprudzs R; Gao XZ
Cancer Genet Cytogenet; 1998 Jul; 104(1):57-60. PubMed ID: 9648560
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic characterization of a BCR-ABL transduced mouse cell line.
Rudolph C; Hegazy AN; von Neuhoff N; Steinemann D; Schröck E; Stripecke R; Klein C; Schlegelberger B
Cancer Genet Cytogenet; 2005 Aug; 161(1):51-6. PubMed ID: 16080957
[TBL] [Abstract][Full Text] [Related]
10. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment.
Bhatia R; Holtz M; Niu N; Gray R; Snyder DS; Sawyers CL; Arber DA; Slovak ML; Forman SJ
Blood; 2003 Jun; 101(12):4701-7. PubMed ID: 12576334
[TBL] [Abstract][Full Text] [Related]
11. Conventional and fluorescence in situ hybridization analysis of three-way complex BCR-ABL rearrangement in a chronic myeloid leukemia patient.
Ganguly BB; Kadam NN; Agarwal MB
J Cancer Res Ther; 2007; 3(2):124-6. PubMed ID: 17998739
[TBL] [Abstract][Full Text] [Related]
12. Chronic myelomonocytic leukemia with der(9)t(1;9)(q11;q34) as a sole abnormality.
Suh B; Park TS; Kim JS; Song J; Kim J; Yoo JH; Choi JR
Ann Clin Lab Sci; 2009; 39(3):307-12. PubMed ID: 19667417
[TBL] [Abstract][Full Text] [Related]
13. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
[TBL] [Abstract][Full Text] [Related]
14. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.
Ko BS; Tang JL; Lee FY; Liu MC; Tsai W; Chen YC; Wang CH; Sheng MC; Lin DT; Lin KH; Tien HF
Am J Hematol; 2002 Dec; 71(4):291-9. PubMed ID: 12447959
[TBL] [Abstract][Full Text] [Related]
15. Unique secondary chromosomal abnormalities are frequently found in the chronic phase of chronic myeloid leukemia in southern Vietnam.
Phan TX; Hoang AV; Huynh VM; Nguyen KT; Nguyen TB; Huynh N; Pham QT; Tran VB; Tran VB; Tokunaga K; Sato Y
Cancer Genet Cytogenet; 2006 Jul; 168(1):59-68. PubMed ID: 16772122
[TBL] [Abstract][Full Text] [Related]
16. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia.
Hagemeijer A; Buijs A; Smit E; Janssen B; Creemers GJ; Van der Plas D; Grosveld G
Genes Chromosomes Cancer; 1993 Dec; 8(4):237-45. PubMed ID: 7512367
[TBL] [Abstract][Full Text] [Related]
17. [Analysis and identification of variant Ph chromosome translocation in patients with chronic myelogenous leukemia by conventional cytogenetics and fluorescence in situ hybridization].
Liu XP; Liu SH; Li CW; Bo LJ; Qin S; Dai Y; Qian LS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):298-303. PubMed ID: 15228654
[TBL] [Abstract][Full Text] [Related]
18. Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization.
Bentz M; Cabot G; Moos M; Speicher MR; Ganser A; Lichter P; Döhner H
Blood; 1994 Apr; 83(7):1922-8. PubMed ID: 8142658
[TBL] [Abstract][Full Text] [Related]
19. Utility of peripheral blood dual color, double fusion fluorescent in situ hybridization for BCR/ABL fusion to assess cytogenetic remission status in chronic myeloid leukemia.
Landstrom AP; Ketterling RP; Knudson RA; Tefferi A
Leuk Lymphoma; 2006 Oct; 47(10):2055-61. PubMed ID: 17071476
[TBL] [Abstract][Full Text] [Related]
20. The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies.
Lee DY; Cho HI; Kang YH; Yun SS; Park SY; Lee YS; Kim Y; Lee DS
Cancer Genet Cytogenet; 2004 Jul; 152(1):1-7. PubMed ID: 15193435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
